Lipid Management and Interactions with Immunosuppressants in Patients Undergoing Kidney Transplant: Opinions and Prospects.
作者信息
Li Yanqin, Luo Fan, Gao Qi, Su Licong
机构信息
Division of Nephrology, National Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Nanfang Hospital, Southern Medical University, Guangzhou, China.
出版信息
J Am Soc Nephrol. 2024 Jan 1;35(1):129. doi: 10.1681/ASN.0000000000000246.
Abstract
摘要
相似文献
1
Lipid Management and Interactions with Immunosuppressants in Patients Undergoing Kidney Transplant: Opinions and Prospects.肾移植患者的脂质管理及其与免疫抑制剂的相互作用：观点与展望
J Am Soc Nephrol. 2024 Jan 1;35(1):129. doi: 10.1681/ASN.0000000000000246.
2
Authors' Reply: Lipid Management and Interactions with Immunosuppressants in Kidney Transplant Patients: Some Opinions and Prospects.作者回复：肾移植患者的血脂管理及与免疫抑制剂的相互作用：一些观点与展望
J Am Soc Nephrol. 2024 Jan 1;35(1):130. doi: 10.1681/ASN.0000000000000226.
3
Belatacept for kidney transplant recipients.用于肾移植受者的贝拉西普。
Cochrane Database Syst Rev. 2014 Nov 24;2014(11):CD010699. doi: 10.1002/14651858.CD010699.pub2.
4
Systematic Review of Calcineurin Inhibitors and Incidence of Skin Malignancies after Kidney Transplantation in Adult Patients: A Study of 309,551 Cases.钙调磷酸酶抑制剂与成人肾移植后皮肤恶性肿瘤发病风险的系统评价：一项涉及 309551 例患者的研究。
Curr Oncol. 2023 Jun 13;30(6):5727-5737. doi: 10.3390/curroncol30060430.
5
Steroid avoidance or withdrawal for kidney transplant recipients.肾移植受者的类固醇避免或停用
Cochrane Database Syst Rev. 2016 Aug 22;2016(8):CD005632. doi: 10.1002/14651858.CD005632.pub3.
6
Steroid avoidance or withdrawal for kidney transplant recipients.肾移植受者停用或撤减类固醇
Cochrane Database Syst Rev. 2009 Jan 21(1):CD005632. doi: 10.1002/14651858.CD005632.pub2.
7
Immunosuppressive therapy and malignancy in organ transplant recipients: a systematic review.器官移植受者的免疫抑制治疗与恶性肿瘤：一项系统综述
Drugs. 2007;67(8):1167-98. doi: 10.2165/00003495-200767080-00006.
8
Interventions for BK virus infection in kidney transplant recipients.肾移植受者 BK 病毒感染的干预措施。
Cochrane Database Syst Rev. 2024 Oct 9;10(10):CD013344. doi: 10.1002/14651858.CD013344.pub2.
9
Cordyceps sinensis (a traditional Chinese medicine) for kidney transplant recipients.冬虫夏草（一种传统中药）用于肾移植受者。
Cochrane Database Syst Rev. 2015 Oct 12;2015(10):CD009698. doi: 10.1002/14651858.CD009698.pub2.
10
Management of Kidney Disease in Heart Transplant Patients: A National Delphi Survey-based Consensus Expert Paper.心脏移植患者的肾脏疾病管理：一份基于全国德尔菲调查的共识专家论文。
Transplantation. 2025 Feb 7. doi: 10.1097/TP.0000000000005302.
引用本文的文献
1
Authors' Reply: Lipid Management and Interactions with Immunosuppressants in Kidney Transplant Patients: Some Opinions and Prospects.作者回复：肾移植患者的血脂管理及与免疫抑制剂的相互作用：一些观点与展望
J Am Soc Nephrol. 2024 Jan 1;35(1):130. doi: 10.1681/ASN.0000000000000226.
本文引用的文献
1
Statins in Kidney Transplant Recipients: Usage, All-Cause Mortality, and Interactions with Maintenance Immunosuppressive Agents.肾移植受者的他汀类药物：使用、全因死亡率和与维持性免疫抑制剂的相互作用。
J Am Soc Nephrol. 2023 Jun 1;34(6):1069-1077. doi: 10.1681/ASN.0000000000000112. Epub 2023 Mar 9.
2
Using Big Data to Emulate a Target Trial When a Randomized Trial Is Not Available.在没有随机试验时使用大数据模拟目标试验。
Am J Epidemiol. 2016 Apr 15;183(8):758-64. doi: 10.1093/aje/kwv254. Epub 2016 Mar 18.
3
Chapter 2: Pharmacological cholesterol-lowering treatment in adults.第2章：成人药理学降胆固醇治疗
Kidney Int Suppl (2011). 2013 Nov;3(3):271-279. doi: 10.1038/kisup.2013.34.
4
KDIGO clinical practice guideline for the care of kidney transplant recipients.KDIGO 临床实践指南：肾移植受者的护理。
Am J Transplant. 2009 Nov;9 Suppl 3:S1-155. doi: 10.1111/j.1600-6143.2009.02834.x.
Zotero 插件